A clinical trial to study the effects of two therapies-massage and purgation followed by intake of a medicine in Prediabetes.

Pre and post test clinical study to evaluate the combined effect of snehapana followed by virechana and samanaushadhi in reducing FPG, OGTT and HbA1c in Prediabetes

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/06/014637

Enrollment

Registered

2018-06-28

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R730- Abnormal glucose Health Condition 2: null- Prediabetes

Interventions

Intervention1: Snehapana (internal administration of medicated oil): Murchitha Sarsapa Taila in escalating dose for 5 to 7 days at 6 am in empty stomach Intervention2: Sarvanga Abhyanga (full body mas

Eligibility

Inclusion criteria

Inclusion criteria: HbA1C: 5.7 % - 6.4% FPG : 100 mg/dl â?? 125 mg/dl OGTT : 140 mg/dl â?? 199 mg/dl Patient fit for Snehapana and Virechana karma.

Exclusion criteria

Exclusion criteria: HbA1c 6.4 % FPG 125 mg/dl OGTT 199 mg/dl patient unfit for Snehapana and Virechana

Design outcomes

Primary

Measure	Time frame
decrease in FPG level 100 mg/dL, OGTT 140 mg/dL, HbA1c 5.7 %Timepoint: decrease in FPG level 100 mg/dL, OGTT 140 mg/dL, HbA1c 5.7 % after 3 months	—

Secondary

Measure	Time frame
Reduction on symptomsTimepoint: 90th day	—

Countries

India

Contacts

Public ContactDr James Chacko

Amrita School Of Ayurveda

drjameschacko.2008@gmail.com9495191191

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026